Know Cancer

or
forgot password

Nausea and Vomiting In Patients Receiving Consecutive Days of Cisplatin


N/A
18 Years
N/A
Not Enrolling
Both
Metastatic Melanoma, Nausea

Thank you

Trial Information

Nausea and Vomiting In Patients Receiving Consecutive Days of Cisplatin


Questionnaires are completed on week of chemotherapy treatment referred to as Dartmouth
regimen.


Inclusion Criteria:



- confirmed diagnosis metastatic melanoma

- 18 years and older

- undergoing chemotherapy with Dartmouth regimen

- medically stable to receive chemotherapy per physical and clinical laboratory tests

Exclusion Criteria:

- No medical conditions that interfere with assessment of nausea and vomiting during
chemotherapy

- No cognitive disorder that impairs symptom assessment

- No other investigational agent

- Inability to swallow medications for nausea and vomiting

- No gastric outlet obstruction

Type of Study:

Observational

Study Design:

Observational Model: Case-Only

Outcome Measure:

Determine incidence of nausea when receiving Dartmouth regimen chemotherapy for metastatic melanoma

Outcome Time Frame:

Week of treatment

Safety Issue:

No

Principal Investigator

Takami Sato, M.D.,Ph.D.

Investigator Role:

Principal Investigator

Investigator Affiliation:

Thomas Jefferson University

Authority:

United States: Institutional Review Board

Study ID:

05C.202

NCT ID:

NCT00716560

Start Date:

May 2005

Completion Date:

March 2009

Related Keywords:

  • Metastatic Melanoma
  • Nausea
  • Melanoma
  • Nausea
  • Vomiting

Name

Location
Thomas Jefferson University Hospital Philadelphia, Pennsylvania  19131